treatments

Donanemab

A new experimental Alzheimer’s drug called donanemab is generating major excitement as a potential breakthrough in treating the disease. In a large-scale clinical trial sponsored...

Ketamine

Amidst a burgeoning body of research, we’re continually unravelling new facets of the versatile drug ketamine. A case in point is recent studies indicating another...

Advancements in Clinical Trials for Lymphoma Cancer Patients

Lymphoma cancer is a type of cancer that affects the lymphatic system, which is responsible for fighting infections and diseases. While there are several types...

Lilly Bets $630M on Pain Target Novartis Failed: A High-Stakes Gamble in the World of Pharma

In the highly competitive world of pharmaceuticals, companies are constantly looking for the next big breakthrough drug. The quest for new treatments can be a...

It has been called “historic” that the first drug to slow the brain damage caused by Alzheimer’s has been made. The scientific discovery puts a...

Mark Cuban's new pharmacy is bringing down the cost of medications

It is still attempting to resolve the fundamental issue. In general, Mark Cuban’s new online pharmacy is delivering on its promises of offering low savings...